Ignite Creation Date:
2024-05-05 @ 6:33 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00509613
Status:
COMPLETED
Last Update Posted:
2009-09-18
First Post:
2007-07-30
Brief Title:
Phase 1 Study With Sorafenib and Sirolimus
Sponsor:
Radboud University Medical Center
Organization:
Radboud University Medical Center
Organization Data
Organization:
Radboud University Medical Center
Class:
OTHER
Study ID:
UMCNONCO 2006_01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Radboud University Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
CML van Herpen
Old Organization:
University Medical Centre Nijmegen st Radboud
Collaborators
| Name | Class |
|---|---|
| Bayer | INDUSTRY |